Clinical Trial Update: The AminoECMO Pilot Trial [Phase 2]

View source ↗

Summary

The AminoECMO Pilot Trial is a Phase 2 study investigating a treatment for acute kidney injury, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: Australian and New Zealand Intensive Care Research Centre | Conditions: Acute Kidney Injury | Phase 2 | Status: NOT_YET_RECRUITING